NG-monomethyl-L-arginine causes nitric oxide synthesis in isolated arterial rings: trouble in paradise

Biochem Biophys Res Commun. 1992 Oct 30;188(2):590-6. doi: 10.1016/0006-291x(92)91097-a.

Abstract

Arginine analogs are commonly used as inhibitors of the synthesis of endothelium-derived relaxing factor, nitric oxide. However, their effect on nitric oxide levels is rarely measured. Using a chemiluminescence assay for nitric oxide, we found that NG-monomethyl-L-arginine enhanced, rather than reduced, nitric oxide synthesis in pulmonary arterial and aortic rings. NG-monomethyl-L-arginine inhibited relaxation to the endothelium-dependent vasodilator A23187 in aortic but not pulmonary arterial rings. In contrast, N omega-nitro-L-arginine did not stimulate nitric oxide synthesis and it inhibited relaxation to A23187 in all rings. We conclude that NG-monomethyl-L-arginine is a partial agonist for nitric oxide synthesis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Aorta, Abdominal / drug effects*
  • Aorta, Abdominal / metabolism
  • Aorta, Abdominal / physiology
  • Arginine / analogs & derivatives*
  • Arginine / pharmacology
  • Calcimycin / pharmacology
  • Endothelium, Vascular / physiology
  • In Vitro Techniques
  • Muscle, Smooth, Vascular / drug effects*
  • Muscle, Smooth, Vascular / metabolism
  • Muscle, Smooth, Vascular / physiology
  • Nitric Oxide / metabolism*
  • Nitroarginine
  • Phenylephrine / pharmacology
  • Pulmonary Artery / drug effects*
  • Pulmonary Artery / metabolism
  • Pulmonary Artery / physiology
  • Rats
  • Rats, Sprague-Dawley
  • Vasoconstriction / drug effects
  • Vasodilation / drug effects
  • omega-N-Methylarginine

Substances

  • Phenylephrine
  • Nitroarginine
  • omega-N-Methylarginine
  • Nitric Oxide
  • Calcimycin
  • Arginine